HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  


Search:



The Web

Rediff









Business
Portfolio Tracker
Business News
Specials
Columns
Market Report
Mutual Funds
Interviews
Tutorials
Message Board
Stock Talk
Press Releases



Home > Business > Reuters > Report

Ranbaxy gets FDA nod for Fluconazole tablets

May 06, 2003 12:50 IST

Ranbaxy Laboratories has received tentative approval form the Food & Drug Administration USA for manufacturing and marketing Fluconazole tablets, according to a release issued by the company to the Bombay Stock Exchange on Tuesday.

Fluconazole tablets are therapeutically equivalent to the reference listed drug Diflucan tablets of Pfizer Central Research, the release said.

Diflucan is indicated for the treatment of vaginal candidiasis, oropharyngeal and esophageal candidiasis and cryptococcal meningitis, the release added.

© Copyright 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.





Article Tools

Email this Article

Printer-Friendly Format

Letter to the Editor



Related Stories


Ranbaxy witnesses optimism

Ranbaxy gets FDA nod for Serzone



People Who Read This Also Read


Centre to develop 7 clusters

MUL faces claims of Rs 1798 cr

IA announces special discounts







HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  
© 2003 rediff.com India Limited. All Rights Reserved.